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INTRODUCTION 
Neuronal communication and endocrine signaling are fundamental for integrat- 
ing the function of tissues and cells in the body. Hormones released by endocrine 
cells are transported to the target cells through the circulation. By contrast, trans- 
mitter release from neurons occurs at specialized intercellular junctions, the syn- 
apses. Nevertheless, the mechanisms by which signal molecules are synthesized, 
stored, and eventually secreted by neurons and endocrine cells are very similar. 
Neurons and endocrine cells have in common two different types of secretory 
organelles, indicating the presence of two distinct secretory pathways. The synaptic 
vesicles of neurons contain excitatory or inhibitory neurotransmitters, whereas the 
secretory granules (also referred to as dense core vesicles, because of their electron 
dense content) are filled with neuropeptides and amines. In endocrine cells, peptide 
hormones and amines predominate in secretory granules. The function and content 
of vesicles, which share antigens with synaptic vesicles, are unknown for most 
endocrine cells. However, in B cells of the pancreatic islet, these vesicles contain 
GABA, which may be involved in intrainsular signaling.' 
Exocytosis of both synaptic vesicles and secretory granules is controlled by 
cytoplasmic calcium. However, the precise mechanisms of the subsequent steps, 
such as docking of vesicles and fusion of their membranes with the plasma mem- 
brane, are still incompletely understood. This contribution summarizes recent ob- 
servations that elucidate components in neurons and endocrine cells involved in 
exocytosis. Emphasis is put on the intracellular aspects of the release of secretory 
granules that recently have been analyzed in detail. 
SECRETORY ORGANELLE MEMBRANE PROTEINS AND THEIR 
COUNTERPARTS AT THE CELL MEMBRANE 
A variety of membrane proteins, exposed on the cytoplasmic surface of secretory 
organelles, have been suggested to participate in exocytosis. For example, GTP- 
binding proteins (G proteins) have been found in membranes of secretory granuled4 
and synaptic  vesicle^.^ There are several reasons to believe that G proteins are 
involved in docking and/or fusion of secretory granules with the plasma membrane. 
In particular, the effect of GTP and its analogues on exocytosis by chromaffin cellsM 
argues for the participation of these proteins in exocytosis. In nerve terminals, 
synaptic vesicles are used for several cycles of exocytosis, and G proteins control 
OWork in the author's laboratory was supported by the Deutsche Forschungsgemeinschaft. 
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cycling and docking of synaptic vesicles?’” possibly together with additional pro- 
teins, such as rabphilin,” a member of the synaptotagmin family (see below). 
Synaptotagmin was the first membrane protein detected in both synaptic vesicles 
and secretory granules.l? Its presence in chromaffin granules and in neurohypop- 
hysial granules13 has recently been confirmed.14 Synaptotagmin is characterized by 
several interesting properties. Its ability to bind calcium ions in the presence of 
phospholipids suggests a role as a calcium sensor during exocytosis.lS Moreover, 
synaptotagmin interacts with syntaxin, a synaptic protein implicated in docking of 
synaptic vesicles to the plasma men~brane.’~.~’ In addition, synaptotagmin binds to 
the cytoplasmic domain of neurexin, the receptor of alpha latrotoxin, a toxin from 
a spider venom that activates transmitter Finally, peptides corresponding 
to cytoplasmic domains of synaptotagmin are inhibitory to exocytosis of both syn- 
aptic vesicles and secretory granules.zo.21 Taken together, these data are strong 
evidence for the involvement of synaptotagmin and its partners in exocytosis of the 
two major secretory organelles of neurons and endocrine cells. Moreover, the in- 
teraction of synaptotagmin with syntaxin and calcium channels at the plasma mem- 
brane would place these complexes into a favorable position at the site of calcium 
influx that triggers exocytosis.16~zz-24 
Synaptophysin is a member of a family of secretory organelle membrane pro- 
teins. With one exception,zs the known members of the synaptophysin family26 and 
synapt~porin~’,’~ are strictly confined to neurons and endocrine  cell^.'^.^^ At present, 
it is not clear whether members of this protein family exist in secretory granule 
membranes as well as in synaptic  vesicle^.^^.^'-^^ Synaptophysin, which interacts 
with the plasma-membrane component, phy~ophilin,3~ is involved in pore formation 
during exocytosis,3s and antibodies to synaptophysin interfere with transmitter secre- 
tion in neuromuscular synapses.36 
Synaptobrevins (also referred to as vesicle-associated membrane proteins, 
VAMPS), are neural isoforms of ubiquitous intracellular vesicle membrane protein, 
named ~ellubrevin.~’-~~ Recently, two proteins of the plasma membrane, syntaxins 
(also referred to as HPC-1) and the synaptosomal-associated protein, SNAP-25, have 
been uncovered as possible partners of synaptobrevins.4 Because injection of an 
antibody to syntaxin or of different portions of the cytoplasmic domain of syntaxin 
inhibits exocytosis of secretory granules from pheochromocytoma cells, syntaxins 
obviously play an important role in ~ecretion.~’ Further evidence for the participation 
of synaptobrevins, syntaxins, and SNAP-25 in exocytosis will be discussed below. 
TARGETS OF TETANUS AND BOTULINUM TOXINS 
Botulism is caused by a toxin produced in patients infected with Clostridium 
botulinum or by ingestion of food contaminated with the toxin. Blockade of ace- 
tylcholine release at motor end plates by botulinum toxin results in a progressive 
flaccid neuromuscular paralysis, the hallmark of the disease. By contrast, the clinical 
manifestations of tetanus, generalized spasms, are caused by a preferential blockade 
of transmitter release from glycinergic inhibitory intemeurons in the spinal cord by 
tetanus toxin, produced by Clostridium tetani in wounds. It turned out that the 
clostridial neurotoxins are excellent tools for deciphering the molecular mechanisms 
of exocytosis. 
Application of tetanus toxin and botulinum A toxins to intact synaptosomes and 
neurohypophysial nerve endings prevented exocytosis of synaptic vesicles and se- 
cretory gran~les.~?.~’ Thus, the neurotoxins inhibit both secretory pathways charac- 
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terized by these secretory organelles. Moreover, injection of tetanus toxin into 
chromaffin cells revealed that clostridial neurotoxins act from within the cells." In 
addition, permeabilization studies established that the neurotoxins inhibit exocytosis 
at a step downstream the elevation of intracellular ~ a l c i u m . ~ ~ . ~  Cleavage of the 
constituent light and heavy chains of clostridial neurotoxins is a prerequisite for the 
inhibition of exocyt~sis.".~~ Then, the light chains of the neurotoxins alone are active 
within neurons and endocrine ~ e l l s . ~ ~ ~ ~  Thus, the mechanism of the neurotoxins' 
action involves endocytotic internalization of the disulfide-linked light and heavy 
chains, reductive chain separation, and translocation of the light chains from the 
endosome compartment to the cytoplasm. Finally, the light chain inhibits calcium- 
triggered exocytosis, which includes vesicle docking and fusion. 
Although the tetanus toxin light chain when applied within neurohypophysial 
nerve terminals or adrenal chromaffin cells completely inhibits exocytosis, the light 
chain of botulinum A toxin blocks exocytosis only in part.47.48*sz This observation is 
in accordance with recent findings that tetanus toxin and the different types of 
botulinum toxins attack different membrane proteins of secretory organelles or the 
plasma membrane, which have been suggested to participate in the release of neu- 
rotransmitters (see above). SNAP-25, linked to the plasma membrane through fatty 
acids, is cleaved by botulinum A and botulinum E t o ~ i n . ~ ~ . ~ ~  In addition syntaxin, a 
transmembrane protein of the plasma membrane, is a substrate of botulinum C1 
toxin.s8 On the other hand, tetanus toxin cleaves synaptobrevin 2,5M1 a well-con- 
served synaptic vesicle membrane protein. In addition, synaptobrevins can be 
cleaved by botulinum B, D, and F  toxin^.^'^^'.^^ Interestingly, synaptobrevins, SNAP- 
25, and syntaxins, together with soluble proteins, are components of a suggested 
docking and fusion complex.40 A model of the exocytosis machinery and the attack 
sites for clostridial neurotoxins is shown in FIGURE 1.
FUNCTIONAL ANALYSIS OF NEUROTOXIN TARGETS 
Blockade of acetylcholine release from Aplysia neurons by tetanus toxin is 
delayed by peptides spanning the cleavage site of synaptobrevin 2:' and inhibition 
of glutamate release from synaptosomes is paralleled by cleavage of synaptobre~in .~~ 
Moreover, in neurohypophysial nerve terminals, the inhibition of vasopressin release 
by the tetanus toxin light chain is completely abolished by peptides spanning the 
cleavage sites of synaptobrevin 1 or synaptobrevin 2.63 Taken together, these data 
imply that synaptobrevins are centrally involved in exocytosis of synaptic vesicles 
and secretory granules from neurons. 
Surprisingly, peptides that harbor the site of synaptobrevins cleaved by the 
tetanus toxin light chain do not prevent the action of the toxin in the endocrine 
adrenal chromaffin ce lkM Similarly, captopril, an inhibitor of synaptobrevin cleav- 
age and tetanus toxin action in neur0ns,6~.~~ was ineffective in endocrine cells.- 
Moreover, the absence of synaptobrevin from adrenal secretory g r a n ~ l e s ~ ~ , ~  in- 
dicates that, in contrast to neurons, synaptobrevins are not a functional target of 
tetanus toxin in the endocrine chromaffin cells. 
MECHANISM OF TETANUS TOXIN ACTION 
The sequences of many clostridial neurotoxins, including tetanus and botulinum 
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conserved domain with a pattern of histidine residues. The same motif occurs in the 
catalytic site of zinc-dependent peptidases.a Several observations suggest that the 
light chains of clostridial neurotoxins function as peptidases and cleave their sub- 
strates in a zinc-dependent manner. Histidine-specific reagents and chelators for 
divalent cations abrogate the effectivity of tetanus toxin.60 Mutational modification 
of the histidine residues within the zinc-binding motif caused a complete inactivation 
of the neurotoxin when tested in permeabilized neurohypophysial nerve terminals or 
chromaffin ~ e l l s . ~ ~ . ~  Moreover, selective removal of zinc from the tetanus toxin light 
chain by dipicolinic acid reversibly abolished its activity, although restoration of zinc 
yielded a fully active toxin, copper and nickel were only partly effective. By contrast, 
cadmium and cobalt were not effective.M Interestingly, a similar specificity for 
divalent cations was observed during zinc binding studies with isolated tetanus 
toxin.h9 Taken together, these data indicate that zinc and the conserved domain with 
a pattern of histidine residues constitute the active site of clostridial neurotoxins. 
DIFFERENTIAL EXPRESSION AND DEVELOPMENT OF THE 
EXOCYTOSIS MACHINERY 
As outlined in previous sections of this article, there is accumulating evidence 
that synaptophysins, synaptotagmins, and synaptobrevins on organelle membranes 
and SNAP-25, syntaxins, and neurexins at the plasma membrane are key players in 
exocytosis. However, deletions in the synaptotagmin genes7s7’ do not completely 
block exocytosis in the organisms. Moreover, evoked secretion has been reported in 
cell lines devoid of ~ynaptotagmin.’~ In addition, the incomplete block of exocytosis 
by botulinum A t o ~ i n , ~ ~ . ~ ~ . ~ ~  which cleaves SNAP-25,S6*57 indicates redundancy of 
components of the fusion/docking components and the presence of alternate path- 
ways of exocytosis. Finally, not all fusionldocking proteins are present in selected 
neurons. For example, synaptophysins, synaptotagmins, synaptobrevins, and SNAP- 
25 show different patterns of distribution in the central nervous ~ys tem.’~ .~”~* Thus, 
different types of neurons express different combinations of these proteins. During 
development of neurons, secretory vesicle membrane proteins are already found in 
outgrowing fibers and growth During synaptogenesis, they become clus- 
tered in terminals when function unfolds. However, the pattern of the components 
of the dockinglfusion machinery may change during development. For example, 
striatal GABAergic neurons prenatally express synaptophysin, whereas synaptopo- 
rin is the major antigen expressed postnatally.” Developmental loss of SNAP-25 has 
been observed in olfactory glomeruli and other brain areas.8z Thus, nerve terminal 
proteins are differentially expressed in mature and developing neurons. In this way 
the function of the exocytotic machinery can be modulated or adjusted to the 
changing tasks of a neuron within the developing neuronal network. 
In conclusion, it appears that the essential components involved in synaptic 
vesicle or secretory granule exocytosis have been identified with a variety of dif- 
ferent techniques. However, the exact roles of the membrane proteins of the secretory 
organelles and of the plasma membrane of neurons and endocrine cells have yet to 
be delineated. 
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